Santa Clara, CA, United States of America

Randall A Scheuerman

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 109(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations of Randall A Scheuerman: A Pioneer in Pharmaceutical Patents

Introduction

Randall A Scheuerman is an accomplished inventor based in Santa Clara, California. With a prolific portfolio of 20 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs and their applications.

Latest Patents

His recent inventions include crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, which serves as a prodrug of methyl hydrogen fumarate. Scheuerman has disclosed several crystalline forms including Crystalline form 1, Crystalline form 2, Crystalline form 3, and Crystalline form 4, along with methods of synthesis and use, highlighting his commitment to advancing medicinal chemistry.

Career Highlights

Throughout his career, Randall has worked with notable organizations such as Xenoport, Inc. and Syngenta Participations AG. His experience in these companies has undoubtedly shaped his expertise and innovation in the pharmaceutical sector.

Collaborations

Scheuerman has collaborated with esteemed colleagues like Mark A Gallop and Stephen P Raillard, sharing insights and driving advancements in their respective fields.

Conclusion

Randall A Scheuerman stands out as a prominent inventor in the pharmaceutical industry. His contributions, evidenced by his patents and collaborative efforts, continue to influence the development of new therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…